Literature DB >> 8047806

A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Histologic course during the 1st year after presentation.

G Schumacher1, B Kollberg, B Sandstedt.   

Abstract

To investigate the possibilities of differentiating between inflammatory bowel disease (IBD) and infectious colitis on histologic grounds, a prospective histologic study of 105 patients with a first attack of colitis was undertaken. Rectal biopsies were performed on four occasions during 1 year. The strongest predictor of IBD was basal plasmacytosis, followed by more than two vertical crypt branches per medium-power field, crypt distortion, villous mucosa, and mucosal atrophy. These signs were rarely found among patients with infectious colitis. Their frequency increased with the interval between initial symptoms and the first biopsy. To study the development of histologic features in the absence of treatment, the IBD patients were divided into groups depending on this interval. Focal or diffuse basal plasmacytosis increased from 38% in the group with an interval of 1-15 days to 89% in those who presented in 121-300 days, and crypt distortion from 0% to 78%, whereas absence of signs indicating IBD decreased from 62% to 11%. The presence of focal basal plasmacytosis seems to be the earliest sign of IBD. The frequency of histologic signs indicating IBD was maximal (88%) at the 1-week biopsy. After recovery, the basal plasmacytosis and villous mucosa decreased, whereas crypt distortion and mucosal atrophy remained unchanged. Early treatment did not prevent the appearance of any feature.

Entities:  

Mesh:

Year:  1994        PMID: 8047806     DOI: 10.3109/00365529409094843

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  18 in total

1.  Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway.

Authors:  B Moum; A Ekbom; M H Vatn; E Aadland; J Sauar; I Lygren; T Schulz; N Stray; O Fausa
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

Review 2.  Elderly patients and inflammatory bowel disease.

Authors:  Danielle Nimmons; Jimmy K Limdi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

Review 3.  Indeterminate colitis.

Authors:  M Guindi; R H Riddell
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

Review 4.  Crohn's disease and infections: a complex relationship.

Authors:  Gert De Hertogh; Karel Geboes
Journal:  MedGenMed       Date:  2004-08-10

5.  European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis.

Authors:  E F Stange; S P L Travis; S Vermeire; C Beglinger; L Kupcinkas; K Geboes; A Barakauskiene; V Villanacci; A Von Herbay; B F Warren; C Gasche; H Tilg; Stefan W Schreiber; J Schölmerich; W Reinisch
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 6.  Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease.

Authors:  Gert De Hertogh; Jeroen Aerssens; Karen P Geboes; Karel Geboes
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

7.  Histopathological findings of extra-ileal manifestations at initial diagnosis of Crohn's disease-related ileitis.

Authors:  Vincenzo Villanacci; Gabrio Bassotti
Journal:  Virchows Arch       Date:  2017-01-20       Impact factor: 4.064

Review 8.  Early-Onset Inflammatory Bowel Disease.

Authors:  Judith R Kelsen; Pierre Russo; Kathleen E Sullivan
Journal:  Immunol Allergy Clin North Am       Date:  2019-02       Impact factor: 3.479

Review 9.  Histological healing in inflammatory bowel disease: a still unfulfilled promise.

Authors:  Vincenzo Villanacci; Elisabetta Antonelli; Karel Geboes; Giovanni Casella; Gabrio Bassotti
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

10.  The histopathological approach to inflammatory bowel disease: a practice guide.

Authors:  Cord Langner; Fernando Magro; Ann Driessen; Arzu Ensari; Gerassimos J Mantzaris; Vincenzo Villanacci; Gabriel Becheanu; Paula Borralho Nunes; Gieri Cathomas; Walter Fries; Anne Jouret-Mourin; Claudia Mescoli; Giovanni de Petris; Carlos A Rubio; Neil A Shepherd; Michael Vieth; Rami Eliakim; Karel Geboes
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.